The Short Answer
The three hallmark signs of VOD are rapid weight gain (>5% in 3 weeks), yellowing skin or eyes (bilirubin >2.0 mg/dL), and right upper belly pain or fullness. Doctors confirm VOD using ultrasound elastography (liver stiffness >21 kPa) plus blood tests showing elevated bilirubin and liver enzymes [3].
Early symptoms appear 7–21 days after transplant: sudden weight gain (often 2–5 pounds in days), swollen belly, yellowing skin, dark urine, and pale stools [3]. Many patients feel tired and have right upper belly pain or fullness. These signs can overlap with other post-transplant complications (infection, graft-versus-host disease), so blood tests and imaging are essential to confirm VOD diagnosis.
Ultrasound elastography (transient elastography) measures liver stiffness in kilopascals (kPa); values >21 kPa indicate VOD [3]. Blood tests show bilirubin >2.0 mg/dL, elevated liver enzymes (ALT, AST, alkaline phosphatase), and low platelet counts. The ELASTOVOD trial (2025) proved elastography is 85% sensitive and 90% specific for VOD, making it superior to older CT imaging [3].
Diagnosis requires all three criteria: (1) weight gain >5% within 3 weeks post-transplant, (2) bilirubin >2.0 mg/dL, and (3) elastography >21 kPa or right upper belly pain [3]. If you have these signs, your transplant team should start defibrotide within 24–48 hours. Delays beyond 7–10 days sharply reduce recovery odds, so urgent ultrasound and labs are non-negotiable.